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ScienceDirect
journal homepage: www.e- jmii .comLETTER TO THE EDITORSepsis is a more important risk factor
for cytomegalovirus colitis in
human-immunodeficiency virus-negative
adults with chronic kidney diseaseWe read with great interest the article by Chen et al1 in the
Journal of Microbiology, Immunology and Infection. The
authors reported that cytomegalovirus (CMV) disease may
occur in chronic kidney disease patients without overt im-
munodeficiency, and that the gastrointestinal tract, espe-
cially the colon, has been recognized as the most common
site. They also mentioned that chronic kidney disease is a
CMV-prone condition, especially in patients with end-stage
renal disease. A cumulative of risk factors have a greater
risk of CMV reactivation, and sepsis has an extra strong
additive value for risk factor.2
In Chen et al’s1 study, 92.9% of CMV disease is present in
the gastrointestinal tract, and nine patients had colitis. In
our study,2 a retrospective review of 15 patients with a
histopathological diagnosis of CMV colitis showed that the
most common presentation is bloody stool, followed by
persistent diarrhea. Six patients had end-stage renal dis-
ease. Nearly all patients had a condition of sepsis and were
treated with extended (>10 days) broad-spectrum antibi-
otics. Serum anti-CMV immunoglobulin M shows a weak
predictive value, and routine serum test surveillance might
not advance an earlier treatment on CMV disease. In colo-
noscopic view in our patient series, most CMV colitis is
presented as multiple large (>2 cm) geographic shallow
ulcer with profound subepithelial ecchymosis at the distal
colon, and polypoid lesion formation with necrotic tissue
found in patients with advanced disease. All of our patients
received ganciclovir, and four of them died.3
Chen et al1 concluded that CMV disease may occur in
chronic kidney disease patients in the absence of overt
immunodeficiency. But most CMV diseases were related to
CMV reactivation, which is poorly understood in relation to
a chronic kidney disease. Arising evidence indicates that
sepsis is a risk factor for CMV reactivation.2 Listed riskhttp://dx.doi.org/10.1016/j.jmii.2015.01.007
1684-1182/Copyright ª 2015, Taiwan Society of Microbiology. Publishedfactors for CMV disease in an article by Ko et al4 include
neurologic disease, rheumatologic disease, required inten-
sive care, red blood cell transfusion, and exposure to an-
tibiotics, antacids, and steroids. In our study,3 we
suggested that an addition of sepsis to CMV-prone condi-
tions is more likely to be a major contributor in CMV colitis.
We also suggest that other conditions that associated with
sepsis could be presented as bloody stool or persistent
diarrhea. The reasons are that the patient with sepsis with
the use of a broad spectrum antibiotic has an increased risk
of pseudomembranous colitis,5 and that a patient with
septic shock may have the possibility of ischemic colitis.
Both conditions are indistinguishable from CMV colitis
clinically, hence an early endoscopic and histopathological
studies are mandatory.
In summary, a patient with chronic kidney disease who is
concomitant with sepsis has a higher risk of CMV reac-
tivation. Therefore, clinicians should also be aware of the
risk in patients with lower gastrointestinal symptoms.Conflicts of interest
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